UBS raises AMC Networks stock price target on Walking Dead deal
UBS raised its price target for AMC Networks (AMCX) to $10 from $6 but kept a Sell rating. The change reflects higher expected cash generation and visibility from AMC’s Walking Dead licensing deal with Netflix. UBS forecasts adjusted operating income of $374M in 2027 and $250M in 2028, and free cash flow of $240M and $172M.
How this was made
The 30-second read
Why it matters
The note changes expected adjusted operating income and free cash flow for 2027-2028, but maintains a bearish view due to unresolved linear TV weakness and slower streaming growth.
Market read
Traders may use the updated cash-flow model and PT change as a sentiment input, but the Sell rating and secular media headwinds likely limit follow-through.
What to watch
Cash vs revenue timing differences for licensing could create near-term earnings volatility, and the article’s FCF yield framing may not translate into sustained multiple expansion.
Background
UBS updated its AMC Networks valuation assumptions after the Walking Dead licensing deal with Netflix was announced at the company’s second-quarter earnings.
Ticker impact
UBS raised its AMC Networks price target to $10 from $6 while keeping a Sell rating, citing Walking Dead Netflix licensing cash visibility.
Near-term bias is likely mixed: target lift may support sentiment, but Sell rating and secular concerns can cap upside.
The article provides a concrete PT change and updated cash-flow assumptions tied to the Walking Dead licensing deal, but it is still an analyst action rather than a new company disclosure.
Market effects
Highlights how streaming content licensing can improve cash-flow visibility for media companies, even as linear TV faces secular pressure.
Limited, as the catalyst is company-specific analyst modeling rather than a broad regional macro shock.
Low, unless investors generalize the Netflix licensing cash-flow model to other media names.
Counterpoint
The PT increase may be less meaningful if the market already priced the Walking Dead licensing optimism and the Sell rating reflects deeper structural risks.
Key entities
- companyAMC Networks
Subject of the UBS price target change, with valuation assumptions tied to Netflix Walking Dead licensing cash generation.
- analyst_firmUBS
Raised AMC Networks’ price target to $10 from $6 while keeping a Sell rating.
- companyNetflix
Licensing partner for the Walking Dead universe, improving cash-flow visibility per UBS.
